Singapore: Sanofi and the Global Alliance for TB Drug Development (TB Alliance) entered a research collaboration to acce...
Lupin Pharmaceutical, which aims to be the best transnational pharmaceutical company in the world, stroked 10.64 percent...
Singapore: Australian drug delivery technology company Phosphagenics has appointed biotech industry veterans Mr Lawrence...
Singapore: Following successful first-in-man phase I and two phase IIa clinical studies with the oral formulation of fin...
Recent promising data on drug approvals in 2011 shows that there were 35 new molecular entities (NME) approved by the FD...
Singapore: Sweden-based Medivir has discontinued the development of its hepatitis B compound MIV-210 based on a joint de...
Singapore: Eisai revealed its preliminary results from a recently completed phase III study of Halaven versus capecitabi...
Singapore: A study by researchers at the University of Michigan Medical School, US, found that antidepressant drug trany...
Singapore: Australian pharmaceutical company Pharmaxis is all set to launch Bronchitol for cystic fibrosis (CF) patients...
Singapore: UK's Marvel LifeScience, insulin marketing company, has withdrawn its application for centralized marketing a...
Singapore: Alchemia has completed enrollment of patients in a pivotal phase III clinical trial evaluating its lead prod...
Sinapore: Bayer HealthCare in Singapore in collaboration with five research institutions have kaunched new Integrated Tr...
Singapore: Daiichi Sankyo's 24-month randomized, double-blind, placebo-controlled multi-center phase III clinical trial ...
Singapore: Gilead Sciences plans to halt phase III study evaluating idelalisib in previously-treated chronic lymphocytic...
Singapore: Sihuan Pharmaceutical entered into a collaboration agreement with NeuroVive Pharmaceutical to develop two in...
Singapore: Australian company Bioxyne closed its 320-patient study, which was designed to evaluate the efficacy and safe...
Singapore: MicuRx Pharmaceuticals, a privately-held biopharmaceutical company developing next-generation antibiotics, ha...
Singapore: MedImmune, the global biologics R&D arm of AstraZeneca, has entered into a three-year collaboration with ...
